Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
EPS (Diluted)
Cyclopharm Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Cyclopharm Ltd
ASX:CYC
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
Neurotech International Ltd
ASX:NTI
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
0%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
21%
|
CAGR 5-Years
30%
|
CAGR 10-Years
13%
|
|
Cochlear Ltd
ASX:COH
|
EPS (Diluted)
AU$5
|
CAGR 3-Years
N/A
|
CAGR 5-Years
3%
|
CAGR 10-Years
15%
|
|
Optiscan Imaging Ltd
ASX:OIL
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
6%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's EPS (Diluted)?
EPS (Diluted)
-0.1
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's EPS (Diluted) amounts to -0.1 AUD.
What is Cyclopharm Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
12%
Over the last year, the EPS (Diluted) growth was 29%. The average annual EPS (Diluted) growth rates for Cyclopharm Ltd have been 15% over the past three years , and 12% over the past ten years .